Alteplase

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Alteplase and local guidelines before prescribing.

Thrombolytic (tissue plasminogen activator)

Mechanism

Recombinant tissue plasminogen activator converting plasminogen to plasmin to lyse fibrin.

Uses

Acute ischaemic stroke, STEMI where PCI unavailable, massive PE with haemodynamic compromise.

Dosing

1 more dose entries from the chapters

Side effects

Bleeding (including intracranial), hypotension, angioedema, reperfusion arrhythmias.

Interactions

Anticoagulants and antiplatelets increase bleeding risk.

Contraindications and cautions

Active bleeding, recent surgery or stroke, intracranial haemorrhage, severe uncontrolled hypertension, bleeding disorders

Monitoring

BP, neurological status, bleeding, fibrinogen

Pregnancy and breastfeeding

Use only in life-threatening disease

Renal and hepatic impairment

No adjustment

Overdose and reversal

Tranexamic acid and cryoprecipitate for bleeding

Special advice

Strict eligibility and contraindication checks; time window matters; neurological and BP monitoring afterwards.

More from the textbook: uses, cautions and other points
Where it is discussed in the book